Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$293M |
| 2 |
Tyson Foods
TSN
|
+$236M |
| 3 |
JPMorgan Chase
JPM
|
+$236M |
| 4 |
Archer Daniels Midland
ADM
|
+$211M |
| 5 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$573M |
| 2 |
Apple
AAPL
|
+$465M |
| 3 |
Invesco
IVZ
|
+$235M |
| 4 |
Visa
V
|
+$219M |
| 5 |
Citigroup
C
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 7.94% |
| 2 | Financials | 7.83% |
| 3 | Consumer Discretionary | 7.6% |
| 4 | Healthcare | 5.44% |
| 5 | Industrials | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Interactive Brokers
IBKR
$41.7B
| $304K | ﹤0.01% |
48,672
-118,572
| -71% | -$705K |
|
5127
Cytokinetics
CYTK
$10.3B
| $303K | ﹤0.01% |
86,098
+62,843
| +270% | +$264K |
|
5128
Incyte
INCY
$24.4B
| $303K | ﹤0.01% |
6,183
-524,068
| -99% | -$26.3M |
|
5129
CALL
Novavax
NVAX
$1.33B
| $303K | ﹤0.01% |
3,630
-400
| -10% | -$36.2K |
|
5130
Golub Capital BDC
GBDC
$3.44B
| $302K | ﹤0.01% |
19,319
-900
| -4% | -$15K |
|
5131
Gogo Inc
GOGO
$383M
| $302K | ﹤0.01% |
17,912
+4,294
| +32% | +$73.3K |
|
5132
CALL
Hexcel
HXL
$7.87B
| $302K | ﹤0.01% |
7,600
+3,300
| +77% | +$130K |
|
|
SCMP
5133
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $302K | ﹤0.01% |
46,528
-19,169
| -29% | -$127K |
|
|
CVC
5134
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $302K | ﹤0.01% |
17,264
-148,147
| -90% | -$2.74M |
|
5135
Option Care Health
OPCH
$3.59B
| $301K | ﹤0.01% |
10,878
-4,521
| -29% | -$140K |
|
|
FMI
5136
DELISTED
Foundation Medicine, Inc.
FMI
| $301K | ﹤0.01% |
+15,860
| New | +$378K |
|
5137
Brookfield Infrastructure Partners
BIP
$18.3B
| $300K | ﹤0.01% |
19,868
+7,654
| +63% | +$124K |
|
|
RNF
5138
CALL
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
| $300K | ﹤0.01% |
24,100
-5,600
| -19% | -$85.4K |
|
|
EFII
5139
CALL
DELISTED
Electronics for Imaging
EFII
| $300K | ﹤0.01% |
6,800
+5,500
| +423% | +$245K |
|
5140
PUT
Dana Inc
DAN
$3.26B
| $299K | ﹤0.01% |
15,600
+5,800
| +59% | +$132K |
|
5141
Robert Half
RHI
$4.42B
| $299K | ﹤0.01% |
6,102
-714,847
| -99% | -$35.4M |
|
5142
Sanofi
SNY
$105B
| $299K | ﹤0.01% |
+5,300
| New | +$285K |
|
|
ECOM
5143
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $299K | ﹤0.01% |
18,199
-1,555,493
| -99% | -$29.6M |
|
|
ICON
5144
DELISTED
Iconix Brand Group, Inc.
ICON
| $299K | ﹤0.01% |
809
+648
| +402% | +$267K |
|
|
NTK
5145
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $299K | ﹤0.01% |
4,008
+1,142
| +40% | +$94K |
|
|
CFN
5146
CALL
DELISTED
CAREFUSION CORPORATION
CFN
| $299K | ﹤0.01% |
6,600
-1,600
| -20% | -$72.1K |
|
5147
Magna International
MGA
$18.8B
| $298K | ﹤0.01% |
6,274
-40,600
| -87% | -$2.23M |
|
|
IMMU
5148
CALL
DELISTED
Immunomedics Inc
IMMU
| $298K | ﹤0.01% |
80,200
+5,500
| +7% | +$18.6K |
|
5149
PUT
Clean Harbors
CLH
$17B
| $297K | ﹤0.01% |
5,500
-2,000
| -27% | -$118K |
|
|
DMC
5150
PUT
Del Monte Corp
DMC
$1.43B
| $297K | ﹤0.01% |
9,300
+9,000
| +3,000% | +$281K |
|
Similar funds
Ken Griffin's Q3 2014 Portfolio in Review
As of Q3 2014, Ken Griffin held 8,903 positions worth $95.5B, up 9.4% from $87.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin deployed $4.75B of net new capital in Q3 2014, opening 941 new positions and adding to 3,966 existing holdings. Its largest new stake was Liberty TripAdvisor Holdings, Inc. Series A: 5,382,881 shares worth $182M.
By sector, the portfolio is most concentrated in Energy at 7.9% of assets, up from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $573M trimmed.
- Ken Griffin's largest Q3 2014 buy was Liberty TripAdvisor Holdings, Inc. Series A: 5,382,881 shares worth $182M.
- Ken Griffin added most to Invesco QQQ Trust in Q3 2014, an estimated $293M increase.
- Ken Griffin's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $573M.
- Ken Griffin fully exited INTERMUNE INC in Q3 2014, selling an estimated $52.7M.
- Ken Griffin's ten largest holdings make up 16% of its $95.5B portfolio in Q3 2014.
- Ken Griffin opened 941 new positions and closed 818 in Q3 2014.
- Ken Griffin's portfolio value rose 9.4% quarter-over-quarter to $95.5B.
Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.